Schizophrenia Spectrum and Other Psychotic Disorders

SCHIZOPHRENIA SPECTRUM AND OTHER PSYCHOTIC DISORDERS 1 Credit CME Association Between Antipsychotic Use and COVID-19 Mortality Among People With Serious Mental Illness JAMA Psychiatry

PSYCHIATRY AND BEHAVIORAL HEALTH 1 Credit CME Analysis of COVID-19 Infection and Mortality Among Patients With Psychiatric Disorders, 2020 JAMA Network Open

PHARMACOEPIDEMIOLOGY 1 Credit CME Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age JAMA Internal Medicine

PSYCHIATRY AND BEHAVIORAL HEALTH 22m 4s Perturbations in Gut Microbiota Composition in Psychiatric Disorders JAMA Psychiatry

OBSTETRICS AND GYNECOLOGY 20m 22s Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum ... JAMA

PEDIATRICS 17m 5s Development Over Time of the PARF for Cannabis Use Disorder in Schizophrenia in Denmark JAMA Psychiatry

HIV 1 Credit CME What We Know About Long-acting Injectable Antipsychotics Can Help Innovate HIV Care AMA Journal of Ethics

CORONAVIRUS (COVID-19) 1 Credit CME Association of Psychiatric Disorders With Mortality Among Patients With COVID-19 JAMA Psychiatry

CARDIOLOGY 15m 37s Association Between Cardiovascular Risk Factors and Cognitive Impairment in People With Schizophrenia JAMA Psychiatry

PSYCHIATRY AND BEHAVIORAL HEALTH 19m 5s 1 Credit CME Association of Psychiatric Disorders With Mortality Among Patients With COVID-19 JAMA Psychiatry

PSYCHIATRY AND BEHAVIORAL HEALTH 1 Credit CME Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial JAMA Psychiatry

PSYCHIATRY AND BEHAVIORAL HEALTH 1 Credit CME Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial JAMA Psychiatry

PSYCHIATRY AND BEHAVIORAL HEALTH 20m 23s Prevention of Psychosis—Advances in Detection, Prognosis, and Intervention JAMA Psychiatry

CLINICAL CHALLENGE 1 Credit CME Treatment of First-Episode Schizophrenia in a Young Woman JAMA Psychiatry

CHILD AND ADOLESCENT PSYCHIATRY 1 Credit CME Association Between Parental Income During Childhood and Risk of Schizophrenia Later in Life JAMA Psychiatry

CHILD AND ADOLESCENT PSYCHIATRY 1 Credit CME Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services With Anxiety, Mood, and Psychotic Disorders JAMA Psychiatry

PSYCHIATRY AND BEHAVIORAL HEALTH 24m 30s Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia JAMA Psychiatry

PSYCHIATRY AND BEHAVIORAL HEALTH 1 Credit CME Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical Trial JAMA Psychiatry

CLINICAL PHARMACY AND PHARMACOLOGY 1 Credit CME Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial JAMA

PSYCHIATRY AND BEHAVIORAL HEALTH 14m 52s Assessment of Psychosis Risk Among Refugees JAMA Psychiatry